Article info
Background
Improving on effective antiretroviral therapy: how good will a cure have to be?
- Correspondence to Dr Kenneth A Freedberg, MD, MSc, Medical Practice Evaluation Center, Massachusetts General Hospital, 50 Staniford St, Suite 901, Boston, MA, 02114, USA; KFREEDBERG{at}mgh.harvard.edu
Citation
Improving on effective antiretroviral therapy: how good will a cure have to be?
Publication history
- Received August 26, 2016
- Revised October 24, 2016
- Accepted November 3, 2016
- First published December 5, 2016.
Online issue publication
January 25, 2017
Article Versions
- Previous version (25 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
- Testing strategies to detect acute and prevalent HIV infection in adult outpatients seeking healthcare for symptoms compatible with acute HIV infection in Kenya: a cost-effectiveness analysis
- The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
- Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa
- Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
- Cost-effectiveness of implementing HIV and HIV/syphilis dual testing among key populations in Viet Nam: a modelling analysis
- Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study
- Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
- Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
- The role of HIV viral load in mathematical models of HIV transmission and treatment: a review